The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

Thirty-day outcome following carotid artery stenting: a 10-year experience from a single center.

TitleThirty-day outcome following carotid artery stenting: a 10-year experience from a single center.
Publication TypeJournal Article
Year of Publication2010
AuthorsKarkos, C. D., Karamanos D. G., Papazoglou K. O., Demiropoulos F. P., Papadimitriou D. N., & Gerassimidis T. S.
JournalCardiovasc Intervent Radiol
Volume33
Issue1
Pagination34-40
Date Published2010 Feb
ISSN1432-086X
KeywordsAdministration, Oral, Adult, Aged, Aged, 80 and over, Angiography, Carotid Stenosis, Comorbidity, Endarterectomy, Carotid, Female, Humans, Hyperlipidemias, Hypertension, Logistic Models, Male, Middle Aged, Premedication, Prognosis, Retrospective Studies, Risk Factors, Stents, Stroke, Survival Analysis, Ticlopidine, Treatment Outcome
Abstract

We aimed to present our experience with carotid angioplasty and stenting (CAS) and to document how the technique evolved over the last decade (1997-2007). A retrospective study of 333 patients (259 men; median age, 69 years) who underwent 336 CAS procedures. Of these, 118 (35%) patients were symptomatic and 164 (49%) lesions involved the left carotid bifurcation. The first 163 patients received a balloon-expandable stent, whereas the remaining 173 received a self-expandable one. Cerebral protection devices were used in the last 84 (25%) procedures. Access was via the femoral artery in all but six cases, in which direct puncture of the common carotid was necessary. The left common carotid originated from the innominate artery in 18 cases (5%). Conversion to open endarterectomy was necessary in two patients due to inability to remove the filter. Perioperative neurological events included stroke in 6 patients (1.8%), transient ischemic attack in 15 (4.5%), and hyperperfusion syndrome in 10 (3.0%). Three patients died during the first 30 days. As a result, the mortality and the combined stroke/death rate were 0.9 and 2.4%, respectively, with no differences between symptomatic and asymptomatic patients. Bradycardia was noted in 48 patients (14%), and hypotension in 45 (13%). Univariate analysis identified hypertension (P = 0.03), hyperlipidemia (P = 0.02), and current or ex-smoking (P = 0.02) as significant risk factors for death/stroke. On multivariate analysis using logistic regression, only hyperlipidemia [odds ratio (OR), 53.90; 95% confidence interval (CI), 4.19-693.47; P = 0.002] and current or ex-smoking (OR, 63.84; 95% CI,: 4.80-848.68; P = 0.001) remained statistically significant. In conclusion, CAS can be performed safely and effectively, with acceptable mortality, stroke/death, and cardiovascular complication rates. Although technological advances (stent design, cerebral protection devices), perioperative pharmacological management, and increasing experience are all clinically significant factors influencing the short-term results, none appeared to be statistically significant in this patient sample.

DOI10.1007/s00270-009-9746-9
Alternate JournalCardiovasc Intervent Radiol
PubMed ID19908086

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.